OncoLink at ASTRO 2001: Monday, November 5

The OncoLink Team provides comprehensive session coverage throughout the day.

OncoLink Team From left to right: Dr. Ryan Smith, Mia Levesque, Dr. William Levin and Dr. James Metz, OncoLink's Editor-in-Chief

A Phase I/II Trial of Escalating Doses of Recombinant Human Keratinocyte Growth Factor (rHuKGF) in Head & Neck Cancer (HNC) Patients Receiving Radiotherapy (RT) with Concurrent Chemotherapy (CCT) Presenter: D.M. Brizel Presenter's Affiliation: Duke University Type of Session: Scientific Background Evidence from recent studies suggest that the combination of chemotherapy and radiation therapy improves outcome in advanced head and neck cancers,...
A Phase II Study of External Irradiation and Weekly Paclitaxel for Non-Metastatic, Unresectable Pancreatic Cancer: A Preliminary Report of RTOG Protocol 98-12 Presenter: T. Rich Affiliation: University of Virginia Type of Session: Scientific Background Unresectable/locally advanced pancreatic cancer remains a difficult disease to treat, with median survival of less than 1 year This is a new...
B.I.D. Radiotherapy and Chemotherapy With CDDP/5-FU in Unresectable Pharyngeal Carcinoma: 10 Years Experience at the Centre Antoine-Lacassagne. Impact of Tumoral EGFR Level on Response and Survival Presenter: R.J. Bensadoun Presenter's Affiliation: Radiotherapy, Centre A-Lacassagne, NICE, France Type of Session: Scientific Background Combination chemotherapy/radiation therapy regimens are increasingly being employed in the management of...
CANCER AND LEUKEMIA GROUP B (CALGB) 89805: Phase II Chemoradiation Trial using Gemcitabine in Patients with Locoregional Adenocarcinoma of the Pancreas Presenter: A.W. Blackstock Affiliation: CALGB Type of Session: Scientific Background Pancreatic cancer has a high mortality without significant changes in life expectancy over the past several years 50% have distant disease at diagnosis and...
Chemo-Radiotherapy, as Compared to Radiotherapy Alone, Significantly Increases Disease-Free and Overall Survival in Head and Neck Cancer Patients After Surgery: Results of EORTC Phase III Trial 22931 Presenter: J. Bernier Presenter's Affiliation: Radio-Oncology, Ospedale San Giovanni, Bellinzona, Switzerland Type of Session: Plenary Background Standard adjuvant therapy for advanced head and neck cancer in the post-operative setting is radiation...
Control of Regional Metastasis after Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma Presenter: D. Chua Affiliation: Queen Mary Hospital, The University of Hong Knog Type of Session: Scientific Background Nasopharyngeal cancer has a high incidence of metastases. The evidence of regional nodal meastases may be the most...
Conventionally Fractionated Stereotactic Radiotherapy for Vestibular Schwannoma: Long-Term Outcome and Cranial Nerve Function Presenter: Chan, A Presenter's Affiliation: Massachusetts Gerneral Hospital, Boston, MA Type of Session: Scientific Background Vestibular schwannoma/acoutic neuroma comprises 8% of all primary brain tumors. It?s location ? closely associated with...
Gemcitabine, Paclitaxel, and Radiation for Locally Advanced Pancreatic Cancer: A Phase I Trial Presenter: T. Dipetrillo Presenter's Affiliation: Brown University Type of Session: Scientific Background Locally advanced pancreatic cancer has Gemcitabine and paclitaxel are both radiation sensitizers The use of paclitaxel has demonstrated...
Involved-Field Radiotherapy in Patients with Stage III/IV Hodgkin's Lymphoma: First Results of the Randomized EORTC Trial # 20884 Presenter: B.M. Aleman Presenter's Affiliation: EORTC Lymphoma Group, Brussels, Belgium Type of Session: Plenary Background While the role of radiation therapy in the treatment of early stage Hodgkins Disease is well established, its utility in...
Is the Therapeutic Index Better with Gemcitabine-Based Chemoradiation Presenter: Christopher Crane Affiliation: M.D. Anderson Cancer Center Type of Session: Scientific Background Locally advanced pancreatic cancer is both radioresistant and chemoresistant. "Traditional" treatment with concurrent 5-FU...
Mature Survival Results with Preoperative Cisplatin, Protracted Infusion 5-FU, and 45 GY Radiotherapy for Esophageal Cancer Presenter: L. Kleinberg Presenter's Affiliation: Johns Hopkins Oncology Center, Baltimore, MD Type of Session: Scientific Background Neoadjuvant chemoradiation for Esophageal cancer is controversial, however, many patients are offered this therapy...
Preliminary Results of the GORTEC 96-01 Randomized Trial, Comparing Very Accelerated Radiotherapy Versus Concomitant Radio-Chemotherapy for Locally Inoperable HNSCC Presenter: J. Bourhis Presenter's Affiliation: Institut Gustave Roussy, Villejuif, France Type of Session: Plenary Background There is some clinical evidence that radiation therapy administered over a shorter period of time offers better tumor...
Radiation Alone (RT) Versus RT with Concomitant Chemotherapy (CT) in Stages III and IV Oropharynx Carcinoma. Final Results of the 94-01 GORTEC Randomized Study Presenter: Bourhis, J Presenter's Affiliation: GORTEC, Tours, France Type of Session: Reporting Background This study was designed to test whether the addition of three cycles of chemotherapy during standard radiation therapy would improve...
Sequencing of Chemotherapy and Radiation Therapy for Patients with Early Stage Breast Cancer: Updated Results of a Prospective Randomized Trial Presenter: Bellon, JR Presenter's Affiliation: Harvard Medical School Type of Session: Plenary Background This study was designed to evaluate the optimal sequencing of radiation therapy and chemotherapy in early stage breast cancer patients treated...
Simultaneous Gemcitabine/Cisplatin and Radiotherapy for Patients with Locally Advanced Pancreatic Adenocarcinoma using a Strict GEM/RT Time Schedule. A Phase I/II Study Presenter: T. Brunner Presenter's Affiliation: University Hospitals Erlangen, Erlangen, Germany Type of Session: Scientific Background Patients with locally advanced pancreatic cancer treated with induction chemoradiation (CRT) prior to surgery have...

OncoLink I wish u knew...

Ms. Gambino talks about the complexity of cancer care and the need for patients and families to have help in navigating from diagnosis and treatment decisions to survivorship. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet